Moderna, a Cambridge, MA biotech firm, is developing an experimental coronavirus vaccine that has built immunity in monkeys.
It has also protected the monkeys from becoming infected, according to the results of their new trial study, published in The New England Journal of Medicine.
Moderna's experimental coronavirus vaccine built immunity in monkeys and protected them from becoming infected. https://t.co/0XydTIyAv1
— NECN (@NECN) July 29, 2020
